Gall bladder treatment market information, by disease indications (gallstones, cholecystitis and biliary colic, cholelithiasis and choledocholithiasis, gallbladder polyps, gall bladder cancer), by diagnosis (ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy), by treatment (surgery, drugs), by end users (hospitals & gynecology clinics, academic & research centers) - Global forecast till 2030

Gallbladder Treatment Market Scenario

The Gall bladder Treatment Market is projected to reach USD 28,563.7 Million by 2030 at 8.3% CAGR during the forecast period 2022-2030.The gall bladder is a small pear-shaped located underneath the liver. Its main function is to store the bile produced by liver and pass it along through a duct that empties into the small intestine. Gall bladder diseases affect a large number of people in the world. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013 and they resulted in 106,000 deaths. The major driving factors for the growth of the market are increasing geriatric population, increasing prevalence rate of various gallbladder diseases, and introduction & adoption of advanced diagnostic treatment options. Moreover, increasing awareness of the diseases, rising healthcare expenditure, and rising demand from emerging markets of Asia have fuelled the market growth. However, pain and complications during surgery and asymptomatic nature of gallstones may slow the growth of the market.

Figure- Global gall bladder treatment market, by diseases indication (2016) (%)

Source: American Gastroenterological Association, NCBI, Gastroenterological Society of Australia, British Society of Gastroenterology Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Key Findings

• 
  Ultrasound segment accounts for the largest market share in the global gall bladder treatment market while Computerized tomography (CT) segment is projected to grow at a CAGR of 8.3% during the forecast period from 2022 – 2030.


• Surgery segment accounts for the largest market share in the global gall bladder treatment market by Treatment, this segment is expected to reach USD 28,563.7 Million in 2030

Intended Audience

• Gall Bladder Products Manufacturers


• Gall Bladder Products Providers


• Medical Research Laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors

Research Methodology

 Source: American Gastroenterological Association, NCBI, Gastroenterological Society of Australia, British Society of Gastroenterology Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Segments  

Global gall bladder treatment market has been segmented on the basis of disease indications, diagnosis, treatment and end users. On the basis of disease indications the market is segmented as gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis, gallbladder polyps, gall bladder cancer. On the basis of diagnosis the market is categorized as ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy and others. On the basis of treatment the market is segmented into surgery, and drugs and on the basis of end users the market is divided into hospitals & gynecology clinics, academic & research centers and others.

Regional analysis     

Considering the global scenario of the market, North America dominates the global gall bladder treatment market owing to the presence of huge population suffering from gall bladder diseases. US holds the largest market share in North America gall bladder treatment market. In developed countries, 10–15% of adults have gallstones. Europe has the second largest market for the gall bladder treatment which is followed by Asia Pacific. Presence of well-developed healthcare sector and high healthcare expenditure, the gall bladder treatment market in Europe is growing at a CAGR of 6.8%. Asia Pacific is also witnessing a rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, presence of huge population, rising healthcare expenditure and government support for research & development. Asia Pacific gall bladder treatment market is expected to grow at a CAGR of 7.0% during the forecasted period. The Middle East & Africa is expected to have limited growth.

Key players for global gall bladder treatment market   

Some of the major players in this market are: Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others The report for Global Gall Bladder Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions